Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or ...

Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Across 21 countries, proportion of 12-month person-disorders receiving effective treatment was 6.9 percent. (HealthDay News) — A small number of individuals with mental and substance use disorders ...

The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug or alcohol use disorder have entered any type of inpatient or outpatient ...

The use of stigmatizing terminology in National Institute on Drug Abuse (NIDA)-funded grant abstracts has decreased by over ...

Kennedy Jr. is now the Secretary of Health and Human Services. Hours after Kennedy was sworn in, President Donald Trump ...

"Love Is Blind" contestant Devin Buckley admits to being addicted to ibuprofen. But is that possible? Here, MDs explain ...

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

A Fresh Start Family Focused Recovery Center just opened in Columbus. It is for pregnant women and women with children who ...